Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?
oleh: Li-Min Zhao, Miao Zhang, Ze-Lin Zhan, Mei Qiu
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2021-05-01 |
Deskripsi
Subjek
SGLT2 inhibitors; RAS blockers; type 2 diabetes mellitus; cardiorenal events; Heart failure